论文部分内容阅读
In the recent years,the development of novel nanocarriers for biomedical applications,especially for cancer therapy,has strongly attracted the attention of the scientific community.Among them,mesoporous silica nanoparticles (MSNs) (pore size of 2-50 nm) have been widely used to construct controlled drug delivery systems[1,2].